Novus Biotechnology Fund 1, L.P. — Form D/A
Novus Biotechnology Fund 1, L.P. of Portage, MI, a company, filed a Form D amendment with the SEC on 2015-07-02. The offering totals $20.0M, of which $2.0M was reported sold. Industry: Investing.
Offering
- Filed: 2015-07-02
- Form: D/A
- Accession: 0001622840-15-000001
- Industry: Investing
- Exemptions: 06b
- Total offering: $20.0M
- Amount sold: $2.0M
- Remaining: $18.0M
- Minimum investment: $100K
- Investors: 17
- Date of first sale: 2014-06-25
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-228209
Issuer
- Name: Novus Biotechnology Fund 1, L.P.
- CIK: 0001622840
- Entity type: Limited Partnership
- Jurisdiction: DELAWARE
- Incorporated: 2013
- Address: 1151 W. Milham Ave, Portage, MI, 49081
- Phone: 269-207-0656
Officers, directors & promoters (6)
| Name | Role | Location |
|---|
| Kenneth John Easton | Executive Officer | Portage, MI |
| John John Keller | Executive Officer | Portage, MI |
| Kevin McLeod | Executive Officer | Portage, MI |
| Matthew John Milanowski | Executive Officer | Portage, MI |
| Frank Saltiel | Executive Officer | San Jose, CA |
| Gregory Schultz | Executive Officer | Portage, MI |
Other filings by this issuer (1)
More